Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulationsThe company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.Products:Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.Aptus CD care: Focused on chronic therapiesAptus Wellcare: Offers wellness and nutraceutical productsAptus Global: Export in overseas marketAs of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.As of March 31, 2025, the company had 70 employees.Competitive StrengthsDiversified product portfolioRobust distribution networkStrategic manufacturing alliances across Gujarat, Uttarakhand and Himachal PradeshCompetitive and cost-effective pricingExperienced management team
| Category | Shares Offered* | Total Amt* (₹ Cr.) |
|---|---|---|
|
Anchor
|
94,000 | ₹0.660 |
|
QIB (Ex Anchor)
|
880,000 | ₹6.160 |
|
NII
|
266,000 | ₹1.860 |
|
Retail
|
620,000 | ₹4.340 |
| Total ** | 1,860,000 | ₹13.020 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 4,000 | ₹280,000 |
| Retail (Max — 13 Lots) | 13 | 26,000 | ₹1,820,000 |
| S-HNI (Min — 14 Lots) | 14 | 28,000 | ₹1,960,000 |
| S-HNI (Max — 66 Lots) | 66 | 132,000 | ₹9,240,000 |
| B-HNI (Min — 67 Lots) | 67 | 134,000 | ₹9,380,000 |
| Category | QIB | NII | Retail | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (No. of shares) | — | — | — | — | — | 266,000 | 620,000 | 886,000 |
| Allotment price (Rs.) | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (Rs.cr.) | 6.16 | 0.66 | 6.82 | — | — | 1.86 | 4.34 | 13.02 |
| No. of times subscribed | — | — | — | — | — | — | — | — |
| No. of shares allotted | — | — | — | — | — | 266,000 | 620,000 | 886,000 |
| Amount (Rs.cr.) | 6.16 | 0.66 | 6.82 | — | — | 1.86 | 4.34 | 6.20 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Category | Shares Offered | Amt (₹ Cr) | Size (%) |
|---|---|---|---|
| Anchor / Market Maker | 94,000 | ₹0.66 |
5.05%
|
| QIB (Ex Anchor) | 880,000 | ₹6.16 |
47.31%
|
| NII / HNI | 266,000 | ₹1.86 |
14.30%
|
| Retail (RII) | 620,000 | ₹4.34 |
33.33%
|
| Total | 1,860,000 | ₹13.02 |
100.00%
|
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 24.64 | 17.88 | 13.90 |
| EBITDA | 4.76 | 1.49 | 0.57 |
| Profit After Tax (PAT) | 3.10 | 0.80 | 0.19 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Total Assets | 21.92 | 10.03 | 6.22 |
| Reserves & Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowings | 10.36 | 5.31 | 2.21 |
| EBITDA Margin (%) | 19.31% | — | — |
| PAT Margin (%) | Not Available | — | — |
Aptus Pharma Ltd proposes to utilize the net proceeds raised through this IPO for the following objects as stated in the Draft Red Herring Prospectus (DRHP) filed with SEBI: